Surajeet Das Gupta &Amp; Sohini Das

Stories by Surajeet Das Gupta &Amp; Sohini Das

COVID-19 Vaccine: Vial, syringe makers ramp up

COVID-19 Vaccine: Vial, syringe makers ramp up

Rediff.com   2 Jan 2021

'The government should put the whole road map together for the vaccine and decide how industry can support...' 'They should allow the private sector to vaccinate.'

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Rediff.com   31 Dec 2020

The expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine.

Kids will have to wait for a COVID-19 vaccine

Kids will have to wait for a COVID-19 vaccine

Rediff.com   28 Dec 2020

The primary objective was to get the adult vaccine as children rarely have a severe form of the disease. Once schools reopen, the demand for vaccines for children under 12 may soar.

COVID vaccine: States to use bank guarantees

COVID vaccine: States to use bank guarantees

Rediff.com   26 Dec 2020

Each of the larger states may need less than Rs 10,000 crore each to finance the exercise.

Is Reliance Jio's 5G plan realistic?

Is Reliance Jio's 5G plan realistic?

Rediff.com   23 Dec 2020

Surajeet Das Gupta explains why Mukesh Ambani's target is by no means impossible.

New rules will make Ola, Uber's life tougher

New rules will make Ola, Uber's life tougher

Rediff.com   22 Dec 2020

Just a few weeks ago, the Centre has come out with the long-awaited Motor Vehicle Aggregator Guidelines, which have drawn a dismayed response from the companies concerned.

Wistron: 'We made mistakes as we expanded'

Wistron: 'We made mistakes as we expanded'

Rediff.com   22 Dec 2020

iPhone SE 2020 is one of the popular phones like Apple 11, which is the biggest seller in the domestic market.

Centre may not get costly Pfizer vaccine

Centre may not get costly Pfizer vaccine

Rediff.com   22 Dec 2020

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield.

Sunil Mittal's $2 bn gamble on space

Sunil Mittal's $2 bn gamble on space

Rediff.com   18 Dec 2020

Bharti Global is planning to put up more satellites and has set a stiff deadline to launch commercial Internet services by October in the UK, Alaska, northern Russia and northern Europe.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com   17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

Sovereign fund flow: India replaces China as most sought-after destination

Sovereign fund flow: India replaces China as most sought-after destination

Rediff.com   17 Dec 2020

In the year 2020 to date, these funds deployed capital worth a record $14.8 billion in India, which is nearly three times more than what they have put in China - $4.5 billion.

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com   17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.

Will Reliance be real estate's new disruptor?

Will Reliance be real estate's new disruptor?

Rediff.com   16 Dec 2020

A stake sale of Reliance's real estate portfolio would help it raise anything between $1-5 billion and could be one of the triggers for the company's shares to break out.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com   14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.

Is this Indian Covid vaccine better than Pfizer's?

Is this Indian Covid vaccine better than Pfizer's?

Rediff.com   12 Dec 2020

India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.

Covishield volunteer decides to move court against Serum Institute

Covishield volunteer decides to move court against Serum Institute

Rediff.com   11 Dec 2020

'Our client is suffering due to the ill-effects of the vaccine. He has to be compensated for his suffering. Further, a detailed investigation has to be done on the Covishield vaccine and its side-effects,' says the volunteer's advocate.

Why Modi visited Serum's Covid vaccine unit

Why Modi visited Serum's Covid vaccine unit

Rediff.com   10 Dec 2020

The PM's visit would signal a strong intent towards making sure India becomes a beneficiary as vaccines become a massively traded commodity in the coming years.

Sunil Mittal's son Shravin ups his reputation as VC investor

Sunil Mittal's son Shravin ups his reputation as VC investor

Rediff.com   10 Dec 2020

Shravin Mittal's venture capital firm, Unbound Advisors, has made investments worth over $500 million so far

Serum Institute set to sign deal with Centre for Covishield

Serum Institute set to sign deal with Centre for Covishield

Rediff.com   9 Dec 2020

By January-February, it's expected to have at least 100 million doses for the Indian government, reports Sohini Das.

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com   7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.